Related Experiment Video
Updated: Aug 6, 2026
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
Published on: January 31, 2012
Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro
M Piperno1, P Reboul, M P Hellio Le Graverand
1Centre Hospitalier Lyon Sud, Claude Bernard University, 165 chemin du Grand Revoyet, Pierre Bénite, France.
Objective:
The efficacy of glucosamine sulfate (GS) in the symptomatic treatment of patients with osteoarthritis (OA) is suggested to be mediated by still unknown effects on the altered OA cartilage.
Design:
Using human OA chondrocytes in culture, the effects of GS on protein synthesis, caseinase, collagenase, phospholipase A2 (PLA2) and protein kinase C (PKC) activities as well as production of nitric oxide and cyclic AMP were studied in both cells and culture medium.
Results:
GS significantly reduced PLA2 activity, and more modestly collagenase activity, in the OA chondrocytes in a dose-dependent manner. By contrast, PLA2 and collagenase activity of the culture medium was not modified. No effects on caseinase activity was seen. GS significantly and dose-dependently increased protein synthesis. GS did not modify nitric oxide and cAMP production but significantly increased PKC production.
Conclusion:
GS modified cultured OA chondrocyte metabolism by acting on PKC, cellular PLA2, protein synthesis and possibly collagenase activation. Extrapolation of the effect to the in-vivo situation remains hypothetical but they might represent some possible mechanisms of action of the drug in human.
Insights
Glucosamine sulfate (GS) impacts osteoarthritis (OA) cartilage by increasing protein synthesis and protein kinase C (PKC) production. It also reduces phospholipase A2 (PLA2) and collagenase activity in OA chondrocytes, potentially explaining its therapeutic effects.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
- The therapeutic mechanisms of glucosamine sulfate (GS) in OA symptomatic treatment are not fully understood.
- Altered cartilage metabolism is a key feature of OA pathogenesis.
Purpose of the Study:
- To investigate the effects of glucosamine sulfate (GS) on the metabolic activity of human OA chondrocytes.
- To elucidate potential mechanisms by which GS may exert its therapeutic effects in OA.
Main Methods:
- Human OA chondrocytes were cultured in vitro.
- The study assessed the impact of GS on protein synthesis, caseinase, collagenase, phospholipase A2 (PLA2), and protein kinase C (PKC) activities.
- Production of nitric oxide and cyclic AMP was also measured in cells and culture medium.
Main Results:
- GS demonstrated a dose-dependent reduction in cellular PLA2 and collagenase activity.
- Protein synthesis and PKC production were significantly increased by GS in a dose-dependent manner.
- No significant effects were observed on caseinase activity, nitric oxide, or cyclic AMP production.
Conclusions:
- Glucosamine sulfate (GS) modulates OA chondrocyte metabolism through effects on PKC, cellular PLA2, protein synthesis, and potentially collagenase activation.
- These findings suggest possible in vivo mechanisms of action for GS in human OA.
- Further research is needed to confirm these effects in clinical settings.
